2019 -- H 5751 SUBSTITUTE A | |
======== | |
LC001618/SUB A/4 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2019 | |
____________ | |
H O U S E R E S O L U T I O N | |
CREATING A SPECIAL LEGISLATIVE COMMISSION TO STUDY THE EFFICACY OF | |
INVOLUNTARY INPATIENT TREATMENT FOR NON-COURT INVOLVED | |
INDIVIDUALS DIAGNOSED WITH SUBSTANCE USE DISORDER | |
| |
Introduced By: Representatives Casey, Canario, Jacquard, Hull, and Morin | |
Date Introduced: February 27, 2019 | |
Referred To: House Judiciary | |
1 | RESOLVED, That a special legislative commission be and the same is hereby created |
2 | consisting of seventeen (17) members: three (3) of whom shall be members of the Rhode Island |
3 | House of Representatives, not more than two (2) from the same political party, to be appointed by |
4 | the Speaker of the House; one of whom shall be the Director of the Rhode Island Department of |
5 | Health (RIDOH), or designee; one of whom shall be the Director of the Rhode Island Department |
6 | of Behavioral Healthcare, Developmental Disabilities, and Hospitals, or designee; one of whom |
7 | shall be from the Warren Alpert Medical School of Brown University, to be appointed by the |
8 | Speaker of the House; one of whom shall be the Rhode Island Mental Health Advocate, or |
9 | designee; one of whom shall be the President of the Hospital Association of Rhode Island, or |
10 | designee; one of whom shall be the Rhode Island state Attorney General, or designee; one of |
11 | whom shall be a representative of the health insurance industry, to be appointed by the Speaker of |
12 | the House; three (3) of whom shall be representatives from groups that work with or advocate for |
13 | persons who experience mental illness of substance use disorders, to be appointed by the Speaker |
14 | of the House; one of whom shall be the President and Chief Operating Officer of Butler Hospital, |
15 | or designee; one of whom shall be the Chief Justice of the Rhode Island Supreme Court, or |
16 | designee; one of whom shall be the Executive Director of the Rhode Island Medical Society, or |
17 | designee; and one of whom shall be of the President of the Rhode Island Chapter of the American |
18 | College of Emergency Physicians, or designee. |
19 | In lieu of any appointment of a member of the legislature to a permanent advisory |
| |
1 | commission, a legislative study commission, or any commission created by a General Assembly |
2 | resolution, the appointing authority may appoint a member of the general public to serve in lieu |
3 | of a legislator. |
4 | The purpose of said commission shall be to examine the need for an advance directive or |
5 | other mechanism to hold persons who are under the immediate effects of a substance use disorder |
6 | involving opioids, and shall include, but not be limited to, a study and review of: |
7 | Medical literature and expert opinions on the long-term relapse rates of individuals |
8 | diagnosed with substance use disorder following involuntary inpatient treatment including: |
9 | The differences in outcomes for coerced and non-coerced patients; |
10 | The potential increased risk of an individual suffering a fatal overdose following a period |
11 | of involuntary treatment; |
12 | The length of time necessary for detoxification of opioids and recommended time |
13 | following detoxification to begin medication-assisted treatment; |
14 | The legal implications of holding a non-court involved individual who is diagnosed with |
15 | substance use disorder but is no longer under the influence of substances; |
16 | Whether the current capacity, including acute treatment services, clinical stabilization |
17 | services, transitional support services and recovery homes, is sufficient to treat individuals |
18 | seeking voluntary treatment for substance use disorder; |
19 | The availability of other treatments for substance use disorder, including those treatments |
20 | used in less restrictive settings; and |
21 | The effectiveness of the existing involuntary commitment procedures pursuant to this |
22 | chapter at reducing long-term relapse rates. |
23 | Forthwith upon passage of this resolution, the members of the commission shall meet at |
24 | the call of the Speaker of the House and organize and shall select a chairperson from among the |
25 | legislators. |
26 | Vacancies in said commission shall be filled in like manner as the original appointment. |
27 | The membership of said commission shall receive no compensation for their services. |
28 | All departments and agencies of the state, shall furnish such advice and information, |
29 | documentary and otherwise, to said commission and its agents as is deemed necessary or |
30 | desirable by the commission to facilitate the purposes of this resolution. |
31 | The Speaker of the House is hereby authorized and directed to provide suitable quarters |
32 | for said commission; and be it further |
33 | RESOLVED, That the commission shall report its findings and recommendations to the |
34 | House of Representatives no later than June 18, 2020, and said commission shall expire on July |
| LC001618/SUB A/4 - Page 2 of 4 |
1 | 13, 2020. |
======== | |
LC001618/SUB A/4 | |
======== | |
| LC001618/SUB A/4 - Page 3 of 4 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
H O U S E R E S O L U T I O N | |
CREATING A SPECIAL LEGISLATIVE COMMISSION TO STUDY THE EFFICACY OF | |
INVOLUNTARY INPATIENT TREATMENT FOR NON-COURT INVOLVED | |
INDIVIDUALS DIAGNOSED WITH SUBSTANCE USE DISORDER | |
*** | |
1 | This resolution would create a seventeen (17) member special legislative study |
2 | commission whose purpose it would be to make a comprehensive study of the efficacy of |
3 | involuntary inpatient treatment for non-court involved individuals diagnosed with substance use |
4 | disorder, and who would report back to the House of Representatives no later than June 18, 2020, |
5 | and whose life would expire on July 13, 2020. |
======== | |
LC001618/SUB A/4 | |
======== | |
| LC001618/SUB A/4 - Page 4 of 4 |